» Authors » Erica L Herzog

Erica L Herzog

Explore the profile of Erica L Herzog including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 101
Citations 3923
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim J, Yuan Y, Agaronyan K, Zhao A, Wang V, Gau D, et al.
Mucosal Immunol . 2025 Jan; PMID: 39884393
Host response aimed at eliminating the infecting pathogen, as well as the pathogen itself, can cause tissue injury. Tissue injury leads to the release of a myriad of cellular components...
2.
Cho S, Herzog E, Thorn S, Sinusas A
EBioMedicine . 2024 Dec; 111:105519. PMID: 39700895
No abstract available.
3.
McGovern J, Perry C, Ghincea A, Herzog E, Shao S, Sun H
Am J Physiol Lung Cell Mol Physiol . 2024 Oct; 328(1):L15-L29. PMID: 39470613
Progressive lung fibrosis is often fatal and has limited treatment options. Though the mechanisms are poorly understood, fibrosis is increasingly linked with catecholamines such as adrenaline (AD) and noradrenaline (NA)...
4.
Ishikawa G, Peng X, Ghincea A, McGovern J, Zielonka J, Jeevanandam A, et al.
bioRxiv . 2024 Sep; PMID: 39314391
Fibrosis contributes to incurable pathologies in vital organs including the lung. Myofibroblasts are fibrogenic effector cells that accumulate via incompletely understood mechanisms. We discovered that α1-adrenoreceptor expressing myofibroblasts receive sympathetic...
5.
Yu S, Hu B, Sun Y, Peng X, Lee C, Woo S, et al.
medRxiv . 2024 Aug; PMID: 39211872
Objective: The lungs of patients with Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) contain inflammatory myofibroblasts arising in association with fibrotic stimuli and perturbed innate immunity. The innate immune DNA...
6.
Lee C, He C, Park J, Lee J, Kamle S, Ma B, et al.
Life Sci Alliance . 2024 Aug; 7(11). PMID: 39209538
No abstract available.
7.
Trujillo G, Regueiro-Ren A, Liu C, Hu B, Sun Y, Ahangari F, et al.
Am J Respir Crit Care Med . 2024 Aug; PMID: 39189851
Rationale: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease for which current treatment options only slow clinical progression. Previously, we identified a subset of patients with IPF with an...
8.
Xiao H, Sylla K, Gong X, Wilkowski B, Rossello-Martinez A, Jordan S, et al.
Adv Healthc Mater . 2024 Jul; 13(30):e2400941. PMID: 38967294
Damage and repair are recurring processes in tissues, with fibroblasts playing key roles by remodeling extracellular matrices (ECM) through protein synthesis, proteolysis, and cell contractility. Dysregulation of fibroblasts can lead...
9.
May C, Noble P, Herzog E, Meffre E, Hansen J
Biochem Biophys Res Commun . 2024 May; 720:150123. PMID: 38759301
The contributions of anti-Topoisomerase 1 (Top1) autoantibodies to the pathophysiology of diffuse cutaneous systemic sclerosis (dcSSc), the most aggressive scleroderma subtype, are unknown. Top1 catalyzes DNA relaxation and unwinding in...
10.
Unterman A, Zhao A, Neumark N, Schupp J, Ahangari F, Cosme Jr C, et al.
Am J Respir Crit Care Med . 2024 May; 210(4):484-496. PMID: 38717443
Changes in peripheral blood cell populations have been observed, but not detailed, at single-cell resolution in idiopathic pulmonary fibrosis (IPF). We sought to provide an atlas of the changes in...